Triana Bio
Lexington, US Β· 9 known investors
Find your way into Triana Bio
109 people in our graph share verified history with the Triana Bio team β schools, employers, funds. One of them is your warm intro.
Jigar Raythathaunlockedknows Patrick Trojer Β· together at Triana Bio
Γ11knows the team Β· via RA Capital
TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer. The company applies a target-first molecular glue discovery platform to pursue disease targets previously considered undruggable.
Founders & leadership
PT

Patrick TrojerinPresident & Chief Executive OfficerPreviously spent six years at Constellation Pharmaceuticals, rising from Vice President of Research to Senior Vice President of Translational Research and EZH2 Franchise Executive before serving as Chief Scientific Officer. He chairs the board of Booster Therapeutics and advises RA Capital Management and BiOrigin, and served on the scientific advisory board of Fulcrum Therapeutics.
Investors Β· 9
Ascenta Capitalβ verifiedWilmington Β· $15M β $30M
Atlas Ventureβ verifiedCambridge Β· $500K β $1M
Lightspeed Venture Partnersβ verifiedMenlo Park Β· $1.7M β $87M
RA Capitalβ verifiedBoston
Bessemer Venture Partnersβ verifiedRedwood City Β· $5M β $100M
Pfizer Venturesβ verified
Pfizer Venture Investments$5M β $20M
OpenSky VenturesreportedLos Angeles
Third Rock VenturesreportedBoston Β· $100K β $5M
Founder mafia
2 people who came through Triana Bio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Triana Bio do?
- TRIANA Biomedicines is a venture-backed biopharmaceutical company developing small-molecule "molecular glue" therapeutics that induce protein:protein interactions to degrade or alter disease-causing target proteins, with an initial focus on targeted protein degradation for cancer. The company applies a target-first molecular glue discovery platform to pursue disease targets previously considered undruggable.
- Who founded Triana Bio?
- Triana Bio was founded by Patrick Trojer.
- Who are Triana Bio's investors?
- Triana Bio's investors include Ascenta Capital, Atlas Venture, Lightspeed Venture Partners, RA Capital, Bessemer Venture Partners, Pfizer Ventures, Pfizer Venture Investments, OpenSky Ventures and 1 more.
- Where is Triana Bio headquartered?
- Triana Bio is headquartered in Lexington, US.







